Trial Profile
Effects of rosuvastatin and ezetimibe on bone turnover markers in type 2 diabetes patients with hypercholesterolemia
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 07 Jul 2009
Price :
$35
*
At a glance
- Drugs Ezetimibe (Primary) ; Rosuvastatin (Primary)
- Indications Hypercholesterolaemia
- Focus Biomarker; Pharmacodynamics
- 07 Jul 2009 New trial record.